Skip to main content
Journal of Arrhythmia logoLink to Journal of Arrhythmia
. 2020 Jun 29;36(4):608–614. doi: 10.1002/joa3.12391

Mechanoelectrical feedback in pulmonary vein arrhythmogenesis: Clinical challenges and therapeutic opportunities

Yen‐Yu Lu 1,2, Yao‐Chang Chen 3, Yung‐Kuo Lin 4,5, Shih‐Ann Chen 6, Yi‐Jen Chen 4,5,7,✉
PMCID: PMC7411213  PMID: 32782628

Abstract

Mechanoelectrical feedback is an important factor in the pathophysiology of atrial fibrillation (AF). Ectopic electrical activity originating from pulmonary vein (PV) myocardial sleeves has been found to trigger and maintain paroxysmal AF. Dilated PVs by high stretching force may activate mechanoelectrical feedback, which induces calcium overload and produces afterdepolarization. These results, in turn, increase PV arrhythmogenesis and contribute to initiation of AF. Paracrine factors, effectors of the renin‐angiotensin system, membranous channels, or cytoskeleton of PV myocytes may modulate PV arrhythmogenesis directly through mechanoelectrical feedback or indirectly through endocardial/myocardial cross‐talk. The purpose of this review is to present laboratory and translational relevance of mechanoelectrical feedback in PV arrhythmogenesis. Targeting mechanoelectrical feedback in PV arrhythmogenesis may shed light on potential opportunities and clinical concerns of AF treatment.

Keywords: atrial fibrillation, mechanoelectrical feedback, pulmonary vein


Mechanoelectrical feedback is an important factor in the pathophysiology of atrial fibrillation. Paracrine factors, effectors of the renin‐angiotensin system, membranous channels or cytoskeleton of pulmonary vein (PV) myocytes may modulate PV arrhythmogenesis directly through mechanoelectrical feedback or indirectly through endocardial/myocardial cross‐talk.

graphic file with name JOA3-36-608-g005.jpg

1. INTRODUCTION

Mechanoelectrical feedback refers to alterations in electrophysiological properties of cell or tissue as a result of changes in the loading conditions. 1 Under pathological conditions or during mechanical perturbations, myocardial stretch results in increased vulnerability to arrhythmias by increasing volume, pressure, or direct distension of a muscle strip. 2 Stretch‐activated mechanisms contribute to local or global changes in cardiac electrophysiology and intracellular calcium (Ca2+) handling. 3 , 4

Pulmonary veins (PVs) contain myocardial sleeves extending from the left atrium (LA), 5 consisting a mixture of working cardiomyocytes and pacemaker cells. 6 Ectopic electrical activities originating from PV myocardial sleeves have been found to both trigger and maintain paroxysmal atrial fibrillation (AF) in humans. 7 Cellular mechanisms proposed for the generation of PV ectopy include increasing automaticity and triggered activity of PV cardiomyocytes. 8 , 9

Stretch‐induced mechanoelectrical feedback has been proven to regulate PV arrhythmogenesis. 10 Stretch receptors have been found in the subendocardial tissues of LA and terminal portions of the PVs, 11 Higher strain occurs in areas adjacent to PV trunks where atrial arrhythmias are most likely to occur. 12 Patients with paroxysmal AF show dilatation of the orifices and proximal portions of their corresponding PVs. 13 Dilated PVs have been reported to associate with high stretch level. 1 PV dilatation provides not only structural alteration but also changes in electrical properties of the PVs, 14 which may enhance PV arrhythmogenicity resulting in a higher incidence of AF development. 15 Mechanoelectrical feedback in dilated PVs with a high stretch level may induce membrane depolarization and prolong action potential (AP) duration in isolated PV cardiomyocytes, which would alter refractoriness and dispersion and increase the vulnerability to AF. 2 , 16 , 17

2. LABORATORY AND TRANSLATIONAL RELEVANCE OF MECHANOELECTRICAL FEEDBACK IN PV ARRHYTHMOGENESIS

Electrophysiological changes of mechanoelectrical feedback include (a) contour changes of cardiac AP, including shortening of AP duration, decrease in resting diastolic potential, and decrease maximum systolic AP amplitude; (b) development of early afterdepolarizations; and (c) ectopic beats originating from afterdepolarization in myocardium sustaining the greatest stretch. 18

The spontaneous activity of PV cardiomyocytes is mainly regulated by Ca2+ homeostasis. 19 The mechanoelectrical feedback increases Ca2+ transient to generate delayed and early afterdepolarization during shortening of AP duration. 10 , 20 Stretch‐dependent regulation of the Ca2+ system is operated via the mechanotransduction process. Stretch may induce Ca2+ overload and produce afterdepolarizations in cardiomyocytes. 21 Its mechanisms involve many signaling cascades that target a diversity of intracellular Ca2+ sources. Stretch modifies cellular Ca2+ homeostasis by increasing the Ca2+ influx via stretch‐activated channels 22 or the secondary effects of Na+ influx, followed by extrusion of Na+ accompanied by Ca2+ influx via sodium/calcium exchanger (NCX). 23 , 24 Moreover, some sarcolemmal voltage‐gated channels, such as L‐type Ca2+ current (I Ca‐L), have been reported to possess mechanosensitivity. 25 Stretch appears to associate with changes to Ca2+ cycling with decreased I Ca‐L, which contributes to increased sarcoplasmic reticulum Ca2+ content despite unchanged or lower Ca2+ reuptake by sarcoplasmic reticulum Ca2+‐ATPase (SERCA) and increased diastolic Ca2+ leak. 26

Acute stretch has been associated with conduction slowing and complex signal formation in the PV‐LA junction in human studies, and prolongation of refractory period in animal studies. 4 The stretch increases PV firing rates and the incidence of spontaneous and triggered activities. 10 Mechanical stretch through activation of stretch‐activated ion channel enhances PV spontaneous activity, contributing to phase 4 depolarization and leads to increase in firing rate. 27 Activation of stretch‐activated channels can also affect both inward and outward ionic currents, resulting in shortening AP duration and increasing automaticity. 16 Most voltage‐sensitive ion channels that give rise to the cardiac AP can be mechanically modulated. Furthermore, medications could affect the mechanosensitivity of ion channels. 28

The effects of altered stretch on PV cardiomyocytes not only influence the internal machinery of cells, in part, via stretch‐activated channels, 29 but also regulate actin filaments which modulate ion channel activity. 30 Stretch‐induced myofilament Ca2+ release is also a strongly coupled form of mechanoelectrical feedback in cardiomyocytes. 31 Release of Ca2+ from the myofilaments propagates through neighboring tissue by a combination of mechanical transduction, Ca2+ diffusion, and Ca2+‐induced Ca2+ release. This triggered detachment of Ca2+ from troponin C has been hypothesized leading toward extra‐systoles. 31 In biopsies from patients with AF, re‐expression of α‐smooth muscle actin in endothelial cells surrounding the PVs contains stress fibers, which contributes to arrhythmogenicity. 32 Cells lose their arrhythmic effects on cardiomyocytes after ablation of this cytoskeletal component. 33 This suggests that stretch‐induced Ca2+ release by modulating actin filaments during structural remodeling may contribute to AF genesis.

3. TARGETING PV ARRHYTHMOGENESIS THROUGH STRETCH MODULATION

3.1. Endothelium‐dependent regulation

PVs contain endothelium and smooth muscle, which may produce nitric oxide (NO) through the enzyme eNOS or iNOS. Previous studies have shown that NO has important regulatory effects on the cardiovascular system. 34 NO has been shown to regulate PV arrhythmogenesis through mechanoelectrical feedback, 35 and reduce the triggered arrhythmias generated by Ca2+ overload. 36 Mechanical stimulation of NO elevates the systolic Ca2+ transient and produces spontaneous Ca2+ sparks during diastole in myocytes contracting against a higher preload or afterload. 37 Perioperative administration of nitroprusside (NO donor) during the rewarming period could prevent postoperative AF in patients undergoing myocardial revascularization, which suggests the anti‐AF effects of nitroprusside. 38 Our previous study showed that nitroprusside could directly suppress spontaneous activity and inhibit delayed afterdepolarization with the decrease of transient inward currents in PV cardiomyocytes. 39 These findings suggest that NO may play a role in PV arrhythmogenesis and become a specific target for pharmacological treatment of AF.

Endothelin appears to act as a mediator in the pathogenesis of hypertension and its complication resulting from mechanical loading. The major site of generation of endothelin‐1 is in endothelial cells. 40 Endothelin‐1 is a potent vasoconstrictor that increases blood pressure and vascular tone. Endothelin‐1 modulates Ca2+ and potassium (K+) currents, and decreases PV spontaneous activity while increasing resting diastolic tension. 41 Endothelin‐1 may have antiarrhythmic potential through its direct electrophysiological effects on PV cardiomyocytes, and is potentially a novel pharmacological agent against AF.

Previous studies indicated small‐conductance Ca2+‐activated K+ (SK) channels plays an important role in maintaining vessel relaxation, 42 while the endothelium is shown to release endothelium‐derived hyperpolarizing factors following activation of SK channels. 43 Apamin (SK channel blocker) increased spontaneous activity and vessel tone in the PVs with a preserved endothelium, and reduced PV spontaneous activity without significantly affecting vessel tone when the endothelium was removed (Figure 1). 44 These findings indicate that SK channel modulation may decrease vessel stretch and PV spontaneous activity.

FIGURE 1.

FIGURE 1

Effects of apamin on automaticity and vessel tone of pulmonary veins (PVs) with or without intact endothelium. A, With intact endothelium, apamin‐increased spontaneous activity and vessel tone in the PVs. B, Apamin decreased spontaneous activity, but did not change vessel tone in denudated PVs. Adopted from Ref. [44] with permission number of 4765180023726 and 4765180023726

3.2. The renin‐angiotensin system regulation

The renin‐angiotensin (Ang) system (RAS) plays a critical role in the pathophysiology of AF, which contributes to onset and maintenance of AF in paced animal models. 45 The most active element of RAS is Ang II. The formation of Ang II involves two main steps: renin cleaves angiotensinogen to form Ang I, and angiotensin‐converting enzyme then cleaves Ang I to form Ang II. In addition, Ang I is hydrolyzed and converted by angiotensin‐converting enzyme into Ang (1‐7). 46 Under pathophysiologic conditions, the local RAS may be more efficient in heart tissue than the systemic RAS. The local RAS may have a significant role in vasculature and cardiac myocytes. 47

Mechanical stretch of cultured rat cardiac myocytes caused a rapid secretion of Ang II, 48 and this autocrine production of Ang II may play a critical role in stretch‐induced arrhythmias. Ang II increases PV spontaneous activity and triggered activity as delayed afterdepolarizations, which may induce AF by increasing PV arrhythmogenic activity. 49 Ang II receptor antagonists have been shown to prevent the occurrence of AF, 45 and the mechanoelectrical feedback by decreasing stretch was proposed as one of the mechanisms. 50 Losartan (Ang II receptor antagonist) could inhibit PV spontaneous activity. In addition, losartan could prevent or attenuate the proarrhythmic effects of Ang II in PV cardiomyocytes. These findings indicate that Ang II receptor antagonists have a direct antiarrhythmic effect through the reduction of the PV arrhythmogenic activity, and also work as an antagonist of Ang II to prevent AF.

Renin‐angiotensin system inhibition could be achieved by renin inhibitors, the first rate‐limiting step in RAS, which are thought to be more efficient than other inhibitors such as angiotensin‐converting enzyme or Ang II receptor antagonists. The renin inhibitor enalkiren has more effect on vasodilatation renal response compared to captopril. 51 Aliskiren decreased I Ca‐L, but increased reverse‐mode NCX current, which reduces Cai2+ transients, and SR Ca2+ content in PV cardiomyocytes. Aliskiren decreased PV diastolic tension, and reduced PV firing rate in a concentration‐dependent manner. 52 These findings may reveal the antiarrhythmic potential of aliskiren.

Ang‐(1‐7) opposes the molecular and cellular effects of Ang II. 53 Previous study has showed that Ang‐(1‐7) decreased I Ca‐L, late sodium current (I Na‐Late), and NCX current in PV cardiomyocytes. 54 These might cause a reduction in Cai2+ transients and SR Ca2+ content, and prevent Cai2+ overload. The effects of Ang‐(1‐7) may reduce the PV spontaneous electric activity and triggered activity, which suggests the anti‐AF potential of Ang‐(1‐7).

3.3. Stretch‐activated channel regulation

Stretch‐activated ion channel blockers were shown to inhibit stretch‐induced changes in AP and afterdepolarizations, 55 and decrease the vulnerability to AF. 56 It was also reported that the stretch‐induced AF in perfused rabbit hearts was successfully inhibited by venom of the tarantula Grammostola spatulata which is a stretch‐activated ion channel blocker. 56 The arrhythmogenic effects caused by high stretch levels in the PVs were reported to be attenuated by stretch‐activated ion channel blockers, gadolinium and streptomycin. 10 The reversal of stretch‐induced shortening of AP duration by gadolinium also prevents the genesis of microreentrant circuits in the PVs. These findings indicate that stretch‐activated ion channel blockers could reduce AF genesis by suppressing the arrhythmogenic activity of the ectopic foci.

3.4. Stretch‐induced cytoskeleton modulation in PV arrhythmogenesis

Cells lose their arrhythmic effects on cardiomyocytes after pharmacological ablation of α‐smooth muscle actin‐containing stress fibers. 33 This suggests that cytoskeletal rearrangement during structural remodeling may contribute to AF genesis. Mechanical stretch activates Ca2+ influx via stretch‐activated channels which are tightly regulated by the actin cytoskeleton. 57 Actin polymerization could be inhibited by either sequestering the free actin monomer pool with drugs such as latrunculin‐B (Lat‐B). 58 Lat‐B modulates stretch‐induced mechanoelectric feedback. Lat‐B decreases stretch‐induced large‐conductance Ca2+‐activated K+ channel current, as well as I Ca‐L, I Na‐Late, and NCX current, which may reduce the Ca2+ i transient amplitudes and the SR Ca2+ content. The decrease in I Ca‐L, I Na‐Late, and NCX current by Lat‐B may be related to the modulation of stretch‐induced changes, which may reduce PV arrhythmogenesis. 23 Moreover, Lat‐B decreases PV spontaneous electrical activity (Figure 2). 59 The antiarrhythmic effects of Lat‐B on the PVs indicated that actin polymerization may play a pivotal role in PV arrhythmogenesis during structural remodeling, and inhibition of actin polymerization could reduce AF inducibility and perpetuation. Therefore, the effects of Lat‐B on Ca2+ regulation may contribute to decreased PV spontaneous electrical activity and attenuated stretch‐induced PV arrhythmogenesis.

FIGURE 2.

FIGURE 2

Effect of stretch and latrunculin‐B (Lat‐B) on pulmonary vein (PV) electrical activity in Langendorff‐perfused rabbit hearts. PV spontaneous electrical activity and bipolar atrial electrogram in atria under stretch with or without Lat‐B (100 nmol/L) treatment. Lat‐B (100 nmol/L) terminates PV burst firing in bipolar atrial electrogram. This figure was originally published in Lu YY, et al Clin Sci. 2016 with permission from the copyright holder 59

4. PROARRHYTHMIC EFFECTS OF INOTROPES VIA MECHANOELECTRICAL FEEDBACK

Conditions accompanied with mechanical stretch of the heart such as aging, 17 high‐blood pressure, heart failure, and valvular dysfunction, 60 may progress to overloaded myocardium and hence lead to decompensated myocardial function. These pathologic conditions are known to be risk factors for AF. 61 Recently, higher NT‐proBNP (cardiac biomarker of myocardial stretch) was found to increase the risk of AF in people with chronic kidney disease. 62 A variety of practical issues affect the development of new therapeutic approaches to AF. Previous studies have found that cardioactive agents such as isoproterenol or caffeine could increase PV arrhythmogenesis in chronic rapid pacing or advanced renal failure. 63 , 64 Agents such as levosimendan, milrinone, and digitalis have shown potential advantages in managing cardiac dysfunction. 65 Digoxin was traditionally used in AF patients with heart failure because of its positive inotropic properties and a reduction in ventricular response. Digoxin increases automaticity and could produce virtually any type of cardiac dysrhythmia, including AF. 66 Our previous study has found that digitalis may increase PV arrhythmogenesis through its effects on Ca2+ homeostasis and mechanoelectrical feedback because of increasing PV vascular tone through the enhanced contractility from its surrounding myocardium, 15 which may contribute to AF occurrence. Similarly, milrinone has also been shown to increase PV arrhythmogenesis through mechanoelectrical feedback at least in part, potentially leading to the increased risk of AF. 67 Levosimendan has vasodilatory properties; it facilitates the opening of adenosine triphosphate‐dependent K+ channels, or inhibits phosphodiesterase III. 68 However, levosimendan increases PV tension through positive inotropic responses from the myocardial sleeve extending from the LA. The increasing PV diastolic tension by levosimendan may result in an acceleration of the spontaneous PV rate and burst firing through mechanoelectrical feedback (Figure 3). 69 Positive inotropes administered to patients with heart failure may improve hemodynamics but are associated with an increased risk of AF. 70 , 71

FIGURE 3.

FIGURE 3

Effects of levosimendan on isolated pulmonary veins (PVs) with spontaneous activity and diastolic tension with or without intact endothelium. A, Levosimendan concentration dependently increases spontaneous activity and diastolic tension in the PVs with intact endothelium. B, Levosimendan did not change spontaneous activity and diastolic tension in denudated PVs. Adopted from Ref. [69] with permission number of 4765781439248

5. IMPACT OF CATHETER ABLATION ON MECHANICAL FEEDBACK INDUCED PV ARRHYTHMOGENICITY

Catheter ablation has been established as a mainstay for the treatment of AF. 72 Greater total PV volume and PV ostial area in paroxysmal AF patients are associated with AF recurrence after catheter ablation. 73 The patients who underwent successful catheter ablation for AF showed an anatomical reverse remodeling with decrease in the ostial areas and the diameters of all four PVs measured 3 months after the procedure. 74 , 75 At 3 months follow‐up period, the mean ostial area was reduced by 14% in left superior PV, 19% in left inferior PV, 14% in right superior PV, and 16% in right inferior PV. 75 Stress‐inducible microRNAs (miRs) plays a role in regulating myocardial remodeling. miR‐150 was downregulated in response to pressure overload and led to a reduction in cardiomyocyte cell size. 76 As compared to participants without AF, patients with AF had lower plasma level of miR‐150, which was increased after catheter ablation. 77 This finding suggests that catheter ablation for AF may reduce structural remodeling in AF patients via modulating transcriptomic profiles triggered by mechanical stretch. B‐type natriuretic peptide, a neurohormone secreted by cardiomyocytes in response to stretching, reduced to within normal range in the AF patients who had no AF recurrence after catheter ablation, 78 , 79 indicating that stretching force must be reduced after catheter ablation. Patients who kept sinus rhythm after ablation exhibited significantly higher levels of SERCA values compared to baseline, as well as compared to those who AF recurrence after ablation at 12‐month follow‐up. 79 Accordingly, the stretch‐induced changes, such as Ca2+ handling, cytoskeletal modulation and RAS regulation, caused by PV dilatation are expected to be improved after successful ablation. However, plasma levels of renin and Ang II remain higher 6 months after catheter ablation. 80 Therefore, successful ablation may not completely normalize stretch‐enhanced cytokines.

6. CONCLUSIONS

Pulmonary vein arrhythmogenesis is crucially dependent on the electrophysiological outcomes and Ca2+ handling characteristics of mechanoelectrical feedback. Multiple stretch‐activated mechanisms play important roles in PV mechanoelectrical feedback, which may contribute to the arrhythmogenic substrate in pathology. This should prompt the exploration of these mechanisms as potential novel therapeutic targets (Figure 4). Excessive mechanical stretch increases PV arrhythmogenesis because of mechanoelectrical feedback. A vicious circle ensues whereby one condition begets one another. Accordingly, targeting mechanoelectrical feedback in PV arrhythmogenesis may lead to potential opportunities for AF treatment.

FIGURE 4.

FIGURE 4

Targeting pulmonary vein (PV) arrhythmogenesis through modulating mechanoelectrical feedback. Ang, angiotensin; Lat‐B, latrunculin‐B; NO, nitric oxide; SK, small‐conductance calcium‐activated potassium

CONFLICT OF INTEREST

The authors declare no conflict of interest for this article.

ACKNOWLEDGEMENTS

None.

Lu Y‐Y, Chen Y‐C, Lin Y‐K, Chen S‐A, Chen Y‐J. Mechanoelectrical feedback in pulmonary vein arrhythmogenesis: Clinical challenges and therapeutic opportunities. J Arrhythmia. 2020;36:608–614. 10.1002/joa3.12391

REFERENCES

  • 1. Kamkin A, Kiseleva I, Isenberg G, Wagner KD, Gunther J, Theres H, et al. Cardiac fibroblasts and the mechano‐electric feedback mechanism in healthy and diseased hearts. Prog Biophys Mol Biol. 2003;82:111–20. [DOI] [PubMed] [Google Scholar]
  • 2. Nazir SA, Lab MJ. Mechanoelectric feedback and atrial arrhythmias. Cardiovasc Res. 1996;32:52–61. [PubMed] [Google Scholar]
  • 3. Kohl P, Hunter P, Noble D. Stretch‐induced changes in heart rate and rhythm: clinical observations, experiments and mathematical models. Prog Biophys Mol Biol. 1999;71:91–138. [DOI] [PubMed] [Google Scholar]
  • 4. Walters TE, Lee G, Spence S, Larobina M, Atkinson V, Antippa P, et al. Acute atrial stretch results in conduction slowing and complex signals at the pulmonary vein to left atrial junction: insights into the mechanism of pulmonary vein arrhythmogenesis. Circ Arrhythm Electrophysiol. 2014;7:1189–97. [DOI] [PubMed] [Google Scholar]
  • 5. Nathan H, Eliakim M. The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts. Circulation. 1966;34:412–22. [DOI] [PubMed] [Google Scholar]
  • 6. Cheung DW. Electrical activity of the pulmonary vein and its interaction with the right atrium in the guinea‐pig. J Physiol. 1981;314:445–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–66. [DOI] [PubMed] [Google Scholar]
  • 8. Chen YJ, Chen SA, Chen YC, Yeh HI, Chan P, Chang MS, et al. Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: implication in initiation of atrial fibrillation. Circulation. 2001;104:2849–54. [DOI] [PubMed] [Google Scholar]
  • 9. Chen YC, Chen SA, Chen YJ, Chang MS, Chan P, Lin CI. Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J Am Coll Cardiol. 2002;39:366–72. [DOI] [PubMed] [Google Scholar]
  • 10. Chang SL, Chen YC, Chen YJ, Wangcharoen W, Lee SH, Lin CI, et al. Mechanoelectrical feedback regulates the arrhythmogenic activity of pulmonary veins. Heart. 2007;93:82–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Coleridge JC, Hemingway A, Holmes RL, Linden RJ. The location of atrial receptors in the dog: a physiological and histological study. J Physiol. 1957;136:174–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Satriano A, Vigmond EJ, Schwartzman DS, Di Martino ES. Mechano‐electric finite element model of the left atrium. Comput Biol Med. 2018;96:24–31. [DOI] [PubMed] [Google Scholar]
  • 13. Lin WS, Prakash VS, Tai CT, Hsieh MH, Tsai CF, Yu WC, et al. Pulmonary vein morphology in patients with paroxysmal atrial fibrillation initiated by ectopic beats originating from the pulmonary veins: implications for catheter ablation. Circulation. 2000;101:1274–81. [DOI] [PubMed] [Google Scholar]
  • 14. Nattel S, Maguy A, Le Bouter S, Yeh YH. Arrhythmogenic ion‐channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev. 2007;87:425–56. [DOI] [PubMed] [Google Scholar]
  • 15. Wongcharoen W, Chen YC, Chen YJ, Chen SY, Yeh HI, Lin CI, et al. Aging increases pulmonary veins arrhythmogenesis and susceptibility to calcium regulation agents. Heart Rhythm. 2007;4:1338–49. [DOI] [PubMed] [Google Scholar]
  • 16. Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff‐perfused rabbit heart. Circulation. 1997;96:1686–95. [DOI] [PubMed] [Google Scholar]
  • 17. Pan NH, Tsao HM, Chang NC, Chen YJ, Chen SA. Aging dilates atrium and pulmonary veins: implications for the genesis of atrial fibrillation. Chest. 2008;133:190–6. [DOI] [PubMed] [Google Scholar]
  • 18. Franz MR. Mechano‐electrical feedback in ventricular myocardium. Cardiovasc Res. 1996;32:15–24. [PubMed] [Google Scholar]
  • 19. Nattel S. Basic electrophysiology of the pulmonary veins and their role in atrial fibrillation: precipitators, perpetuators, and perplexers. J Cardiovasc Electrophysiol. 2003;14:1372–5. [DOI] [PubMed] [Google Scholar]
  • 20. Franz MR, Burkhoff D, Yue DT, Sagawa K. Mechanically induced action potential changes and arrhythmia in isolated and in situ canine hearts. Cardiovasc Res. 1989;23:213–23. [DOI] [PubMed] [Google Scholar]
  • 21. Sigurdson W, Ruknudin A, Sachs F. Calcium imaging of mechanically induced fluxes in tissue‐cultured chick heart: role of stretch‐activated ion channels. Am J Physiol. 1992;262:H1110–5. [DOI] [PubMed] [Google Scholar]
  • 22. Gannier F, White E, Garnier D, Le Guennec J‐Y. A possible mechanism for large stretch‐induced increase in [Ca2+]i in isolated guinea‐pig ventricular myocytes. Cardiovasc Res. 1996;32:158–67. [PubMed] [Google Scholar]
  • 23. Noble D, Noble PJ. Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium‐calcium overload. Heart. 2006;92(suppl_4):iv1–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Bers DM, Bassani JW, Bassani RA. Na‐Ca exchange and Ca fluxes during contraction and relaxation in mammalian ventricular muscle. Ann N Y Acad Sci. 1996;779:430–42. [DOI] [PubMed] [Google Scholar]
  • 25. Lyford GL, Strege PR, Shepard A, Ou Y, Ermilov L, Miller SM, et al. alpha(1C) (Ca(V)1.2) L‐type calcium channel mediates mechanosensitive calcium regulation. Am J Physiol Cell Physiol. 2002;283:C1001–C1008. [DOI] [PubMed] [Google Scholar]
  • 26. Eckstein J, Verheule S, de Groot NM, Allessie M, Schotten U. Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria. Prog Biophys Mol Biol. 2008;97:435–51. [DOI] [PubMed] [Google Scholar]
  • 27. Hamaguchi S, Hikita K, Tanaka Y, Tsuneoka Y, Namekata I, Tanaka H. Enhancement of automaticity by mechanical stretch of the isolated guinea pig pulmonary vein myocardium. Biol Pharm Bull. 2016;39:1216–9. [DOI] [PubMed] [Google Scholar]
  • 28. Peyronnet R, Nerbonne JM, Kohl P. Cardiac mechano‐gated ion channels and arrhythmias. Circ Res. 2016;118:311–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Sackin H. Mechanosensitive channels. Annu Rev Physiol. 1995;57:333–53. [DOI] [PubMed] [Google Scholar]
  • 30. Lader AS, Kwiatkowski DJ, Cantiello HF. Role of gelsolin in the actin filament regulation of cardiac L‐type calcium channels. Am J Physiol. 1999;277:C1277–83. [DOI] [PubMed] [Google Scholar]
  • 31. Ter Keurs HE, Wakayama Y, Miura M, Shinozaki T, Stuyvers BD, Boyden PA, et al. Arrhythmogenic Ca(2+) release from cardiac myofilaments. Prog Biophys Mol Biol. 2006;90:151–71. [DOI] [PubMed] [Google Scholar]
  • 32. Eiras S, Narolska NA, van Loon RB, Boontje NM, Zaremba R, Jimenez CR, et al. Alterations in contractile protein composition and function in human atrial dilatation and atrial fibrillation. J Mol Cell Cardiol. 2006;41:467–77. [DOI] [PubMed] [Google Scholar]
  • 33. Rosker C, Salvarani N, Schmutz S, Grand T, Rohr S. Abolishing myofibroblast arrhythmogeneicity by pharmacological ablation of alpha‐smooth muscle actin containing stress fibers. Circ Res. 2011;109:1120–31. [DOI] [PubMed] [Google Scholar]
  • 34. Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ Res. 1996;79:363–80. [DOI] [PubMed] [Google Scholar]
  • 35. Hu YF, Chen YC, Cheng CC, Higa S, Chen YJ, Chen SA. Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway. J Cardiovasc Electrophysiol. 2009;20:200–6. [DOI] [PubMed] [Google Scholar]
  • 36. Kubota I, Han X, Opel DJ, Zhao YY, Baliga R, Huang P, et al. Increased susceptibility to development of triggered activity in myocytes from mice with targeted disruption of endothelial nitric oxide synthase. J Mol Cell Cardiol. 2000;32:1239–48. [DOI] [PubMed] [Google Scholar]
  • 37. Petroff MG, Kim SH, Pepe S, Dessy C, Marban E, Balligand JL, et al. Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes. Nat Cell Biol. 2001;3:867–73. [DOI] [PubMed] [Google Scholar]
  • 38. Cavolli R, Kaya K, Aslan A, Emiroglu O, Erturk S, Korkmaz O, et al. Does sodium nitroprusside decrease the incidence of atrial fibrillation after myocardial revascularization? A pilot study. Circulation. 2008;118:476–81. [DOI] [PubMed] [Google Scholar]
  • 39. Lin YK, Lu YY, Chen YC, Chen YJ, Chen SA. Nitroprusside modulates pulmonary vein arrhythmogenic activity. J Biomed Sci. 2010;17:20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Nakano A, Kishi F, Minami K, Wakabayashi H, Nakaya Y, Kido H. Selective conversion of big endothelins to tracheal smooth muscle‐constricting 31‐amino acid‐length endothelins by chymase from human mast cells. J Immunol. 1997;159:1987–92. [PubMed] [Google Scholar]
  • 41. Udyavar AR, Chen YC, Chen YJ, Cheng CC, Lin CI, Chen SA. Endothelin‐1 modulates the arrhythmogenic activity of pulmonary veins. J Cardiovasc Electrophysiol. 2008;19:285–92. [DOI] [PubMed] [Google Scholar]
  • 42. Taylor MS, Bonev AD, Gross TP, Eckman DM, Brayden JE, Bond CT, et al. Altered expression of small‐conductance Ca2+‐activated K+ (SK3) channels modulates arterial tone and blood pressure. Circ Res. 2003;93:124–31. [DOI] [PubMed] [Google Scholar]
  • 43. Sarkar AX, Sobie EA. Quantification of repolarization reserve to understand interpatient variability in the response to proarrhythmic drugs: a computational analysis. Heart Rhythm. 2011;8:1749–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Chen WT, Chen YC, Lu YY, Kao YH, Huang JH, Lin YK, et al. Apamin modulates electrophysiological characteristics of the pulmonary vein and the Sinoatrial Node. Eur J Clin Invest. 2013;43:957–63. [DOI] [PubMed] [Google Scholar]
  • 45. Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J. 2006;27:512–8. [DOI] [PubMed] [Google Scholar]
  • 46. Keidar S, Kaplan M, Gamliel‐Lazarovich A. ACE2 of the heart: from angiotensin I to angiotensin (1–7). Cardiovasc Res. 2007;73:463–9. [DOI] [PubMed] [Google Scholar]
  • 47. Li Y, Li XH, Yuan H. Angiotensin II type‐2 receptor‐specific effects on the cardiovascular system. Cardiovasc Diagn Ther. 2012;2:56–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Mizuno T, et al. Angiotensin II partly mediates mechanical stress‐induced cardiac hypertrophy. Circ Res. 1995;77:258–65. [DOI] [PubMed] [Google Scholar]
  • 49. Chen YJ, Chen YC, Tai CT, Yeh HI, Lin CI, Chen SA. Angiotensin II and angiotensin II receptor blocker modulate the arrhythmogenic activity of pulmonary veins. Br J Pharmacol. 2006;147:12–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Madrid AH, Bueno MG, Rebollo JM, Marin I, Pena G, Bernal E, et al. Use of irbesartan to maintain sinus rhythm in patients with long‐lasting persistent atrial fibrillation: a prospective and randomized study. Circulation. 2002;106:331–6. [DOI] [PubMed] [Google Scholar]
  • 51. Cordero P, Fisher ND, Moore TJ, Gleason R, Williams GH, Hollenberg NK. Renal and endocrine responses to a renin inhibitor, enalkiren, in normal humans. Hypertension. 1991;17:510–6. [DOI] [PubMed] [Google Scholar]
  • 52. Tsai CF, Chen YC, Lin YK, Chen SA, Chen YJ. Electromechanical effects of the direct renin inhibitor (aliskiren) on the pulmonary vein and atrium. Basic Res Cardiol. 2011;106:979–93. [DOI] [PubMed] [Google Scholar]
  • 53. Castro CH, Santos RA, Ferreira AJ, Bader M, Alenina N, Almeida AP. Evidence for a functional interaction of the angiotensin‐(1–7) receptor Mas with AT1 and AT2 receptors in the mouse heart. Hypertension. 2005;46:937–42. [DOI] [PubMed] [Google Scholar]
  • 54. Lu YY, Wu WS, Lin YK, Cheng CC, Chen YC, Chen SA, et al. Angiotensin 1–7 modulates electrophysiological characteristics and calcium homoeostasis in pulmonary veins cardiomyocytes via MAS/PI3K/eNOS signalling pathway. Eur J Clin Invest. 2018;48:1–7. [DOI] [PubMed] [Google Scholar]
  • 55. Bode F, Katchman A, Woosley RL, Franz MR. Gadolinium decreases stretch‐induced vulnerability to atrial fibrillation. Circulation. 2000;101:2200–5. [DOI] [PubMed] [Google Scholar]
  • 56. Bode F, Sachs F, Franz MR. Tarantula peptide inhibits atrial fibrillation. Nature. 2001;409:35–6. [DOI] [PubMed] [Google Scholar]
  • 57. Ito S, Suki B, Kume H, Numaguchi Y, Ishii M, Iwaki M, et al. Actin cytoskeleton regulates stretch‐activated Ca2+ influx in human pulmonary microvascular endothelial cells. Am J Respir Cell Mol Biol. 2010;43:26–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Spector I, Shochet NR, Kashman Y, Groweiss A. Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells. Science. 1983;219:493–5. [DOI] [PubMed] [Google Scholar]
  • 59. Lu YY, Lin YK, Wen ZH, Chen YC, Chen SA, Chen YJ. Latrunculin B modulates electrophysiological characteristics and arrhythmogenesis in pulmonary vein cardiomyocytes. Clin Sci (Lond). 2016;130:721–32. [DOI] [PubMed] [Google Scholar]
  • 60. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population‐based cohort. J Am Coll Cardiol. 1999;33:1948–55. [DOI] [PubMed] [Google Scholar]
  • 61. Kalifa J, Jalife J, Zaitsev AV, Bagwe S, Warren M, Moreno J, et al. Intra‐atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation. 2003;108:668–71. [DOI] [PubMed] [Google Scholar]
  • 62. Lamprea‐Montealegre JA, Zelnick LR, Shlipak MG, Floyd JS, Anderson AH, He J, et al. Cardiac biomarkers and risk of atrial fibrillation in chronic kidney disease: the CRIC study. J Am Heart Assoc. 2019;8:e012200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Chen YJ, Chen SA, Chang MS, Lin CI. Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation. Cardiovasc Res. 2000;48:265–73. [DOI] [PubMed] [Google Scholar]
  • 64. Huang SY, Chen YC, Kao YH, Hsieh MH, Chen YA, Chen WP, et al. Renal failure induces atrial arrhythmogenesis from discrepant electrophysiological remodeling and calcium regulation in pulmonary veins, sinoatrial node, and atria. Int J Cardiol. 2016;202:846–57. [DOI] [PubMed] [Google Scholar]
  • 65. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;2016(37):2129–200. [DOI] [PubMed] [Google Scholar]
  • 66. Irons GV Jr, Orgain ES. Digitalis‐induced arrhythmias and their management. Prog Cardiovasc Dis. 1966;8:539–69. [DOI] [PubMed] [Google Scholar]
  • 67. Feneck RO, Sherry KM, Withington PStuart, Oduro‐Dominah A; European Milrinone Multicenter Trial Group . Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth. 2001;15:306–15. [DOI] [PubMed] [Google Scholar]
  • 68. Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology. 2006;104:556–69. [DOI] [PubMed] [Google Scholar]
  • 69. Lin YK, Chen YC, Chen YA, Huang JH, Chen SA, Chen YJ. Levosimendan differentially modulates electrophysiological activities of sinoatrial nodes, pulmonary veins, and the left and right atria. J Cardiovasc Electrophysiol. 2018;29:1150–8. [DOI] [PubMed] [Google Scholar]
  • 70. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, et al. Outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure I. Short‐term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287:1541–7. [DOI] [PubMed] [Google Scholar]
  • 71. Frommeyer G, Kohnke A, Ellermann C, Dechering DG, Kochhauser S, Reinke F, et al. Acute infusion of levosimendan enhances atrial fibrillation in an experimental whole‐heart model. Int J Cardiol. 2017;236:423–6. [DOI] [PubMed] [Google Scholar]
  • 72. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation. 2019;140:e125–51. [DOI] [PubMed] [Google Scholar]
  • 73. Shimamoto K, Miura F, Shimatani Y, Nishioka K, Inoue I. Pulmonary vein volume predicts the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation. PLoS One. 2018;13:e0201199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Rettmann ME, Holmes DR 3rd, Breen JF, Ge X, Karwoski RA, Monahan KH, et al. Measurements of the left atrium and pulmonary veins for analysis of reverse structural remodeling following cardiac ablation therapy. Comput Methods Programs Biomed. 2015;118:198–206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Wu JH, Li HK, Couri DM, Araoz PA, Lee YH, Ma CS, et al. Reversal of pulmonary vein remodeling after catheter ablation of atrial fibrillation. J Geriatr Cardiol. 2016;13:163–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, et al. A signature pattern of stress‐responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA. 2006;103:18255–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. McManus DD, Tanriverdi K, Lin H, Esa N, Kinno M, Mandapati D, et al. Plasma microRNAs are associated with atrial fibrillation and change after catheter ablation (the miRhythm study). Heart Rhythm. 2015;12:3–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Yamada T, Murakami Y, Okada T, Yoshida N, Toyama J, Yoshida Y, et al. Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation. Europace. 2007;9:770–4. [DOI] [PubMed] [Google Scholar]
  • 79. Sardu C, Santulli G, Guerra G, Trotta MC, Santamaria M, Sacra C, et al. Modulation of SERCA in patients with persistent atrial fibrillation treated by epicardial thoracoscopic ablation: the CAMAF study. J Clin Med. 2020;9(2):544 10.3390/jcm9020544 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Nakazawa Y, Ashihara T, Tsutamoto T, Ito M, Horie M. Endothelin‐1 as a predictor of atrial fibrillation recurrence after pulmonary vein isolation. Heart Rhythm. 2009;6:725–30. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Arrhythmia are provided here courtesy of Japanese Heart Rhythm Society

RESOURCES